New drug tested to fight Tick-Borne parasite infection
NCT ID NCT06207370
First seen Nov 21, 2025 · Last updated Apr 19, 2026 · Updated 16 times
Summary
This study is testing whether adding an oral drug called tafenoquine to the standard antibiotic treatment helps hospitalized babesiosis patients get better faster. Babesiosis is a parasitic infection spread by ticks. Researchers will compare symptom recovery time in about 33 adults who receive either the new drug or a placebo pill along with their usual hospital care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BABESIOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Tufts Medical Center
RECRUITINGBoston, Massachusetts, 02111, United States
Contact Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.